Improving Cancer Care for Transgender Patients
Transgender patients with cancer may be less likely to receive adequate care and have worse outcomes than their cisgender counterparts.
Transgender patients with cancer may be less likely to receive adequate care and have worse outcomes than their cisgender counterparts.
Researchers estimated that 1 in 8 women will be diagnosed with invasive breast cancer in their lifetime, and 1 in 39 will die of breast cancer.
Women with breast cancer are twice as likely as men with breast cancer to achieve a pCR with neoadjuvant chemotherapy, data suggest.
Researchers at Brigham and Women’s Hospital investigated the skin cancer prevention behaviors of these rarely studied ethnic groups.
Low-income cancer survivors have increased odds of not being able to see a doctor and reduced odds of having health insurance coverage.
Black patients with multiple myeloma may not have equitable access to clinical trials of CAR T-cell therapy or bispecific antibodies.
The incidence of distant-stage cervical cancer in the United States increased by 1.3% per year from 2001 to 2018.
A survey of sexual and gender-minority people identified discrimination in the health care system as a barrier to advance care planning.
Men tend to have a higher risk of cancer than women, and factors such as smoking, alcohol use, and diet do not appear to explain this disparity.
Cancer patients with HIV do not receive curative or palliative care in the same way as their HIV-negative peers.